|1.||Brandi, Alberto: 2 articles (01/2014 - 05/2010)|
|2.||Cordero, Franca M: 2 articles (01/2014 - 05/2010)|
|3.||Giomi, Donatella: 1 article (01/2014)|
|4.||Grelli, Sandro: 1 article (05/2010)|
|5.||Minutolo, Antonella: 1 article (05/2010)|
|6.||Macchi, Beatrice: 1 article (05/2010)|
|7.||Mastino, Antonio: 1 article (05/2010)|
|8.||Cardona, Francesca: 1 article (05/2010)|
|9.||Chen, Wen: 1 article (01/2007)|
|10.||Ye, Jian-Liang: 1 article (01/2007)|
01/01/2014 - "The non-natural enantiomer, (-)-lentiginosine, induces apoptosis on tumor cells of different origin and is poorly cytotoxic towards non-transformed cells. "
05/01/2010 - "D-(-)-Lentiginosine [(-)-4], the nonnatural enantiomer of the iminosugar indolizidine alkaloid L-(+)-lentiginosine, acts as apoptosis inducer on tumor cells of different origin, in contrast to its natural enantiomer. "
01/01/2007 - "Spiroketals and the corresponding aza-spiroketals are the structural features found in a number of bioactive natural products, and in compounds possessing photochromic properties for use in the area of photochemical erasable memory, self-development photography, actinometry, displays, filters, lenses of variable optical density, and photomechanical biomaterials etc. And (1R,8aS)-1-hydroxyindolizidine (3) has been postulated to be a biosynthetic precursor of hydroxylated indolizidines such as (+)-lentiginosine 1, (-)-2-epilentiginosine 2 and (-)-swainsonine, which are potentially useful antimetastasis drugs for the treatment of cancer. "
|3.||Biocompatible Materials (Biomaterials)